Journal profile · Medicine-Immunology and Allergy
VacciMonitor
ISSN 1025-028X · eISSN 1025-0298 · Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros · Cuba
VacciMonitor: diamond open access (no APC); no APC; review about 16 weeks (community reports); 17 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
VacciMonitor is published by Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros. By OpenAlex counts of its recent articles, its largest topics are Bacterial Infections and Vaccines, Microbial infections and disease research and Bacterial Identification and Susceptibility Testing, together about 28.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Immunology and Allergy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bacterial Infections and VaccinesImmunology and Microbiology16.2%
- Microbial infections and disease researchImmunology and Microbiology6.6%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5.9%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology5.8%
- Virology and Viral DiseasesMedicine5.2%
- Vaccine Coverage and HesitancySocial Sciences5.1%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.2%
- Animal Virus Infections StudiesAgricultural and Biological Sciences4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Immunology and Allergy | Q4 | 225/234 | 4th |
| Drug Discovery | Q4 | 156/161 | 3rd |
| Molecular Medicine | Q4 | 176/179 | 1st |
| Immunology | Q4 | 239/243 | 1st |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.13LetPub ·
- SNIP 2026-06
- 0.13LetPub ·
- h-index
- 5OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 377 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 11 | 11 | 0 |
| 2025 | 17 | 17 | 6 |
| 2024 | 16 | 16 | 10 |
| 2023 | 16 | 16 | 11 |
| 2022 | 20 | 20 | 6 |
| 2021 | 20 | 20 | 18 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros
- Country or region
- Cuba
- Language
- English, Spanish
- ISSN
- 1025-028X
- Electronic ISSN
- 1025-0298
- Official links
FAQ
Frequently asked questions about VacciMonitor
How long does peer review take at VacciMonitor?
Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index VacciMonitor?
According to LetPub and DOAJ records, VacciMonitor is indexed in Scopus and DOAJ.
Is VacciMonitor open access, and what is the APC?
VacciMonitor is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .